Connect Biopharma Holdings annual debt-to-assets ratio
2021
2022
2023
2024
2025
Connect Biopharma Holdings Debt-to-Assets Ratio Growth & History (CNTB)
Connect Biopharma Holdings's debt-to-assets ratio was 0.01 for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | 0.01 | +600.17% |
| 2024 | 2024-12-31 | 0.00 | −0.01 | −75.93% |
| 2023 | 2023-12-31 | 0.01 | 0.00 | +194.78% |
| 2022 | 2022-12-31 | 0.00 | 0.00 | +476.71% |
| 2021 | 2021-12-31 | 0.00 | — | — |
Connect Biopharma Holdings quarterly debt-to-assets ratio
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | 0.00 | +30.36% |
| Q1 2026 | 2026-03-31 | 0.01 | 0.00 | +13.76% |
| Q4 2025 | 2025-12-31 | 0.01 | 0.01 | +600.17% |
| Q3 2025 | 2025-09-30 | 0.01 | — | — |
| Q2 2025 | 2025-06-30 | 0.01 | 0.01 | +290.16% |
| Q1 2025 | 2025-03-31 | 0.01 | — | — |
| Q4 2024 | 2024-12-31 | 0.00 | −0.01 | −75.93% |
| Q2 2024 | 2024-06-30 | 0.00 | −0.00 | −34.73% |
| Q4 2023 | 2023-12-31 | 0.01 | 0.00 | +194.78% |
| Q2 2023 | 2023-06-30 | 0.00 | 0.00 | +72.77% |
| Q4 2022 | 2022-12-31 | 0.00 | — | — |
| Q2 2022 | 2022-06-30 | 0.00 | — | — |
Connect Biopharma Holdings debt-to-assets ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's debt-to-assets ratio increased from 0.00 to 0.01, a change of 0.01. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings source filings ↗